Business Wire

REPLY: The Internet of Things, Together With the Evolution of 5G and Edge Computing, Is Driving Industrial Innovation

Share

Reply’s latest research Industrial IoT: A Reality Check” explores two key areas that are driving the growth of IoT within the industrial market: smart factory and smart transport & logistics. By connecting machinery and tools, the Industrial IoT (IIoT) enables manufacturing companies to improve the visibility of their production in real time. The huge amount of data generated by Industrial IoT devices constitutes the fuel for optimising production, improving the delivery quality, introducing predictive maintenance, automating the supply chain and much more.

“Without the Industrial IoT, Industry 4.0 cannot exist. Data are the fuel for all “smart” use cases in the industrial world; Industrial IoT is the crucial element that guarantees the infrastructure to collect data, to send them to the cloud and to manage the feedback post-analysis, all as part of a virtuous circle of benefits to business”, explains Filippo Rizzante, Reply CTO.

Market growth

The research, carried out thanks to the data collected with the use of the proprietary Trend Sonar platform and the support provided by the Teknowlogy Group, also examines the main markets for smart factories and smart transport & logistics, grouped into two clusters: “Europe-5” (Germany, Italy, France, Belgium and the Netherlands) and “Big-5” (the USA, China, India, Brazil and the UK).

Despite the though economic climate of 2020, both clusters saw a small growth in investments in smart factories, as well as in the smart transport & logistics area, while further and much more significant growth is expected by 2025. Overall, the smart factory market of the “Big-5” cluster, led by the US, is expected to exceed €86 billion by 2025, with strong investments in platforms, predictive solutions and remote monitoring. The smart transport & logistics market is set to exceed €15 billion. In the “Europe-5” cluster, on the other hand, the smart factory market is expected to nearly triple in all countries, reaching a total of over €23 billion in the five countries in question, with Germany in the lead. Platforms are set to experience exponential growth and businesses will invest to manage quality better and to reduce costs. Germany will also remain the leader in the smart transport & logistics area, but the other countries in the cluster will still see significant growth. This Cluster is expected to reach a total value of €3.6 billion in 2025.

The drive of 5G and edge computing

The adoption of low-cost sensors and 5G networks, driven by large investments by Telcos, will further improve the diffusion of Industrial IoT. For example, improved communication between autonomous vehicles/robots, artificial intelligence and machinery, combined with increased computing power and very low latency, is expected to improve not only the efficiency of plants, but also their safety. Moreover, the ability to create high-density private networks will enable a wider deployment of the Industrial IoT, as well as the connection of a significant number of sensors, machinery, vehicles and robots, complemented by a greater use of augmented and virtual reality to support “connected workers”.

Cybersecurity is a crucial factor

The constant growth of connected devices and their heterogeneity requires bold security management of the setup and maintenance policy of both devices and networks. Based on its experience, Reply believes that organisations need to adopt micro-segmented environments (on-premises and/or cloud-based), which are stable and ready to react to both traditional and new dangerous technologies and techniques, thus reducing the probability that new types of attacks will be successful. The analysis of IoT architecture, of industrial components and of entire infrastructures will help companies to eliminate existing gaps, vulnerabilities and threats in advance. But this is much more than merely a technological issue: training programmes aimed at employees, together with the study and continuous testing of all devices used will also be crucial.

From factories to consumers

If, in recent years, Industrial Internet of Things technologies have been adopted and used, above all, to improve the efficiency of factories and logistics centres, during the pandemic, new investments have been directed primarily towards improving worker safety. The long-term trend, however, is expected to directly involve final consumers. The success of so-called “connected products” is, in fact, accelerating investments towards solutions in which the collection and processing of usage data does not only involve production machinery, but also the use of finished products. The redesign of design, production and distribution processes of IoT-connected products is enabling the creation of value-added services and facilitating the ability to remotely update and maintain household appliances, cars, robots, electronics and entertainment devices.

For more information on the “Industrial IoT: A Reality Check” research. This new research is part of the Reply Market Research series, which includes the “From Cloud to Edge”, “New Interfaces, Zero Interfaces” and “Beyond Digital Marketing” papers.

Reply

Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on the new communication channels and digital media. Through its network of highly specialised companies, Reply partners with major European corporations in the telecoms and media, industry and services, banking and insurance and public administration sectors, to devise and develop business models built on the new paradigms of artificial intelligence, big data, cloud computing, digital media and the Internet of Things. Reply’s services include: Consulting, Systems Integration and Digital Services. www.reply.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contacts
Reply
Fabio Zappelli
f.zappelli@reply.com
Tel. +390117711594

Aaron Miani
a.miani@reply.com
Tel. +44 (0)20 7730 6000

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)18.9.2021 15:34:00 CEST | Press release

Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended use in elderly patients aged 50 years and over, or with at least one underlying medical condition (the obese, cardiovascular disease, chronic lung disease, diabetes, chronic kidney disease, chronic liver disease, and patients with immunosuppressive agents) with mild symptoms of COVID-19, and adult patients with moderate symptoms of COVID-19. This marks the first time a monoclonal antibody treatment for COVID-19 has received a full approval to treat patients with COVID-19 from the Korean MFDS. In February, the Korean MFDS granted a Conditional Marketing Authorisation (CMA) for the emergency use of regdanvimab (CT-P59) and allowed the use of CT-P59 in adult patients aged 60 years and over, or with at least one underlying medical condition (cardiovascular, chronic respiratory disease, diabetes, high blood pressure) w

Ipsen: ESMO 2021: Cabometyx ® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer18.9.2021 06:30:00 CEST | Press release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced presentation of new analyses at the European Society for Medical Oncology (ESMO) Congress 2021 across different forms of cancer for people treated with Cabometyx® (cabozantinib). Of note, the final analysis of the pivotal Phase III COSMIC-311 trial (Abstract LBA67) will be presented, with Cabometyx demonstrating a clinically meaningful, sustained efficacy benefit versus placebo in people living with previously treated radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). With a median follow-up of 10.1 months, Cabometyx continued to demonstrate superior median progression-free survival (mPFS) with a reduction in the risk of disease progression or death of 78% versus placebo (hazard ratio [HR]: 0.22, 96% confidence interval [CI]: 0.15-0.32; p<0.0001).1 This final analysis is consistent with data from the interim analysis, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2021

Unifrax Hosts Groundbreaking Ceremony for SiFAB™ Manufacturing Line17.9.2021 20:46:00 CEST | Press release

Today, Unifrax, a leading manufacturer of high-performance specialty materials, held a ceremonial event celebrating its first large-scale SiFAB™ Silicon Fiber Anode Battery Technology manufacturing line, which is currently under construction at the company’s north central Indiana facility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005495/en/ Unifrax team celebrates SiFAB groundbreaking at New Carlisle plant. (Photo: Business Wire) The event recognized Unifrax’s ongoing partnership with the State of Indiana and St. Joseph County, along with SiFAB’s continued progress. Unifrax executives, along with the SiFAB manufacturing team and local and state government officials, kicked off the ceremony at 10 a.m. EDT at the New Carlisle, IN plant, with remarks by John Dandolph, president and CEO, Unifrax. “Through the support of the State of Indiana and St. Joseph County, we have the ability to leverage our existing New Carli

Prince William announces 15 Finalists for inaugural year of the £50 million Earthshot Prize17.9.2021 19:01:00 CEST | Press release

The Earthshot Prize announces today its first-ever shortlist of 15 Finalists, each with a chance of winning £1million to support their innovative environmental solutions to the greatest challenges facing the planet. Prince William said: "Over half a century ago, President Kennedy’s ‘Moonshot’ programme united millions of people around the goal of reaching the moon. Inspired by this, The Earthshot Prize aims to mobilise collective action around our unique ability to innovate, problem solve and repair our planet. “I am honoured to introduce the 15 innovators, leaders, and visionaries who are the first ever Finalists for The Earthshot Prize. They are working with the urgency required in this decisive decade for life on Earth and will inspire all of us with their optimism in our ability to rise to the greatest challenges in human history.” Launched by Prince William and The Royal Foundation in October 2020, The Earthshot Prize is the most prestigious global environment prize in history. Li

Wipro Announces Co-innovation Space with Google Cloud17.9.2021 15:32:00 CEST | Press release

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced the launch of the Wipro-Google Cloud Innovation Arena in Bangalore, India. This cloud collaboration space will provide in-house technical expertise, ensure seamless cloud adoption, and accelerate innovation to drive business transformation for customers. By combining the expertise and resources of Wipro FullStride Cloud Services and Google Cloud, this jointly developed innovation center will offer a unique combination of people, processes, and platforms that will collectively create a futuristic experience for customers globally. This state-of-the-art arena will showcase the talent, tools and best practices required to develop and deploy applications on Google Cloud. Jason Eichenholz, Senior Vice President, Global Head of Ecosystems & Partnerships, Wipro Limited said, “We are excited to strengthen our partnership with Google Clou

Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat17.9.2021 15:00:00 CEST | Press release

Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, announced today that ReVamp, an upcoming multiplayer social deception game, will launch soon in select markets exclusively for Snapchat. The vampire-themed game will be the first social deception title on Snapchat, giving Snapchatters their first chance to sink their teeth into this popular genre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005012/en/ Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat (Graphic: Business Wire) ReVamp is a real-time multiplayer imposter game where players aim to reveal who the vampire player is among their group of friends while they renovate the rooms of an old mansion. In the game, human players must complete renovation tasks, such as demolition and building, to improve their chances of survival while identifying and defeating the vampire during the voting phase. Vampire players mu

BeiGene Receives Positive CHMP Opinion for BRUKINSA ® (Zanubrutinib) for the Treatment of Adults with Waldenström’s Macroglobulinemia17.9.2021 14:00:00 CEST | Press release

BeiGene (NASDAQ: BGNE; HKEX: 06160) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of BRUKINSA (zanubrutinib) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM) who have received at least one prior therapy or first-line treatment for patients unsuitable for chemo-immunotherapy. “Bruton’s tyrosine kinase (BTK) inhibitors have emerged as a promising treatment for WM, yet treatment discontinuation due to lack of response or side effects remains a concern,” said Prof. Christian Buske, Medical Director at the University Hospital Ulm, Germany, and a trial investigator of the ASPEN study. “The ASPEN trial demonstrated that BRUKINSA provided deep and durable responses and offered substantial improvements in safety and tolerability over standard therapy. Patients in Europe with WM may soon have a new treatment option that can offer improved outcomes.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom